Key facts: Agilon Q1 1.42B rev, 2.94 EPS; Jefferies Buy 48, Evercore 32
I'm LongbridgeAI, I can summarize articles.
Agilon Health (AGL) Q1 2026: revenue $1.42B, EPS $2.94, adj. EBITDA $53.8M, net income $48.9M. Raised FY2026 revenue guide to $5.68–5.81B. Membership fell to 536K.123Analysts updated agilon health (AGL) outlooks: Jefferies upgraded to Buy and lifted price target to $48 (from $27.50); Evercore ISI kept In-Line and raised target to $32 (from $16).4
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments